CSIMarket


National Research Corporation  (NRC)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

National Research Corporation

NRC's Fundamental analysis








National Research's sales fell by -3.18 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 1291

Medical Laboratories industry recorded growth of revenues by 2.68 %

National Research's net profit deacreased by -8.69 % in I. Quarter 2024 year on year, to $6 millions.

More on NRC's Growth


National Research
current PE on trailing twelve month basis is above Medical Laboratories industry average.

National Research PEG ratio is at 8.97 National Research realized cash outflow of $ -0.92per share in trailing twelve-month period.
Company
24.42
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 4.93.
Medical Laboratories industry's Price to Sales ratio is at 3.01.


More on NRC's Valuation
 
 Total Debt (Millions $) 35
 Dividend TTM ($) 1.47 $
 Dividend Yield TTM (%) 1.58 %
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 11.83
 Tangible Book Value (Per Share $) -1.09

National Research
current PE on trailing twelve month basis is above Medical Laboratories industry average.

National Research PEG ratio is at 8.97 National Research realized cash outflow of $ -0.92per share in trailing twelve-month period.
Company
24.42
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 4.93.
Medical Laboratories industry's Price to Sales ratio is at 3.01.

National Research Price to Book Ratio is at 19.68 lower than Indusry Avg. of 420.45. and higher than S&P 500 Avg. of 0.01

More on NRC's Valuation

  Market Capitalization (Millions $) 727
  Shares Outstanding (Millions) 24
  Employees -
  Revenues (TTM) (Millions $) 147
  Net Income (TTM) (Millions $) 30
  Cash Flow (TTM) (Millions $) -22
  Capital Exp. (TTM) (Millions $) -17
  Total Debt (Millions $) 35
  Dividend TTM ($) 1.47 $
  Dividend Yield TTM (%) 1.58 %
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 11.83
  Tangible Book Value (Per Share $) -1.09

  Market Capitalization (Millions $) 727
  Shares Outstanding (Millions) 24
  Employees -
  Revenues (TTM) (Millions $) 147
  Net Income (TTM) (Millions $) 30
  Cash Flow (TTM) (Millions $) -22
  Capital Exp. (TTM) (Millions $) -17


    NRC's Profitability Comparisons
National Research faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2024 to 24.81 % from 30.81 % in IV. Quarter.

National Research net profit margin of 18.01 % is currently ranking no. 3 in Medical Laboratories industry, ranking no. 49 in Healthcare sector and number 644 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 0.41
  Total Debt to Equity (MRQ) 0.95
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 1.19
  Inventory Turnover Ratio (TTM) -



National Research faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2024 to 24.81 % from 30.81 % in IV. Quarter.

National Research net profit margin of 18.01 % is currently ranking no. 3 in Medical Laboratories industry, ranking no. 49 in Healthcare sector and number 644 in S&P 500.

More on NRC's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com